Neuroprotective properties of taurine by Marcin Cieślak, Aleksandra Karmańska, Julia Kaźmierczak-Barańska, Magdalena Korycka, Bolesław Karwowski

Subjects: Get full text

Aducanumab and lecanemab – two novel antibodies against pathologic species of amyloid beta in the treatment of Alzheimer’s disease by Jakub Wojcieszak

“…According to the widely accepted theory, it is caused by neurodegeneration initiated by the deposition of a pathological protein, amyloid β, in the brain. …”
Get full text

Alzheimer's disease - a review of medicinal substances and their derivatives by Marika Więcek, Dorota G. Piotrowska, Michał Kołodziejczyk, Iwona E. Głowacka

“…There are several hypotheses regarding the process of neurodegeneration, however, it is impossible to provide a specific cause of Alzheimer’s disease in humans, due to the lack of in vivo models. …”
Get full text